Ross Klein
Chief Investment Officer at Changebridge Capital and featured guest in this episode, discussing TransMedics and its organ-care technology and market opportunity.
Best podcasts with Ross Klein
Ranked by the Snipd community
Oct 7, 2021 • 31min
Ep. 112: TransMedics with Changebridge Capital CIO Ross Klein, Resources Connection, Kellogg, Lamb Weston Holdings, United Airlines
Ross Klein, Chief Investment Officer at Changebridge Capital, explains TransMedics' organ-care device and market potential. He outlines FDA approvals, how perfusion replaces ice, and the system’s impact on transplant volumes. The conversation also touches on commercialization hurdles, market size and hospital economics.
